Cargando…

CMTM6 Stabilizes PD‐L1 Expression and Is a New Prognostic Impact Factor in Hepatocellular Carcinoma

CKLF‐like MARVEL transmembrane domain containing 6 (CMTM6) was identified as a regulator of programmed death ligand 1 (PD‐L1), which induces antitumor immunity in several cancers. This study aimed to clarify the relationship between CMTM6 and PD‐L1 expression and clinical outcomes in patients with h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yugawa, Kyohei, Itoh, Shinji, Yoshizumi, Tomoharu, Iseda, Norifumi, Tomiyama, Takahiro, Morinaga, Akinari, Toshima, Takeo, Harada, Noboru, Kohashi, Kenichi, Oda, Yoshinao, Mori, Masaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850307/ https://www.ncbi.nlm.nih.gov/pubmed/33553979 http://dx.doi.org/10.1002/hep4.1643

Ejemplares similares

ARID1A Deficiency Is Associated With High Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma
por: Iseda, Norifumi, et al.
Publicado: (2020)

Obesity is a risk factor for intrahepatic cholangiocarcinoma progression associated with alterations of metabolic activity and immune status
por: Yugawa, Kyohei, et al.
Publicado: (2021)

Impact of Metabolic Activity in Hepatocellular Carcinoma: Association With Immune Status and Vascular Formation
por: Itoh, Shinji, et al.
Publicado: (2021)

Impact of Nuclear Factor Erythroid 2–Related Factor 2 in Hepatocellular Carcinoma: Cancer Metabolism and Immune Status
por: Iseda, Norifumi, et al.
Publicado: (2021)

Myeloid-derived suppressor cell infiltration is associated with a poor prognosis in patients with hepatocellular carcinoma
por: Tomiyama, Takahiro, et al.
Publicado: (2022)

Modulation of Nqo1 activity intercepts anoikis resistance and reduces metastatic potential of hepatocellular carcinoma
por: Shimokawa, Masahiro, et al.
Publicado: (2020)

Acute death caused by invasive aspergillosis after living-donor liver transplantation despite good graft function: a case report
por: Tomiyama, Takahiro, et al.
Publicado: (2021)

Impact of JMJD6 on intrahepatic cholangiocarcinoma
por: Kosai-Fujimoto, Yukiko, et al.
Publicado: (2022)

Impact and risk factors for skeletal muscle mass loss after hepatic resection in patients with hepatocellular carcinoma
por: Itoh, Shinji, et al.
Publicado: (2021)

Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor‐4 inhibition in hepatocellular carcinoma
por: Iseda, Norifumi, et al.
Publicado: (2022)

Hemophagocytic syndrome after living donor liver transplantation: a case report with a review of the literature
por: Iseda, Norifumi, et al.
Publicado: (2018)

Primary intrahepatic cholangiocarcinoma with sarcomatous stroma: case report and review of the literature
por: Yugawa, Kyohei, et al.
Publicado: (2018)

Clinical effects of the use of the indocyanine green fluorescence imaging technique in laparoscopic partial liver resection
por: Itoh, Shinji, et al.
Publicado: (2022)

Solitary fibrous tumor in the liver: case report and literature review
por: Yugawa, Kyohei, et al.
Publicado: (2019)

Suppression of optineurin impairs the progression of hepatocellular carcinoma through regulating mitophagy
por: Inokuchi, Shoichi, et al.
Publicado: (2021)

Cancer‐associated fibroblasts promote tumor cell growth via miR‐493‐5p in intrahepatic cholangiocarcinoma
por: Toshida, Katsuya, et al.
Publicado: (2022)

Up‐regulated LRRN2 expression as a marker for graft quality in living donor liver transplantation
por: Tomiyama, Takahiro, et al.
Publicado: (2022)

Multiple hepatic sclerosing hemangiomas: a case report and review of the literature
por: Yugawa, Kyohei, et al.
Publicado: (2018)

Retroperitoneal schwannoma preoperatively diagnosed as liver metastasis from colon cancer: A case report
por: Wang, Huanlin, et al.
Publicado: (2019)

Multiple liver metastases originating from synchronous double cancer of neuroendocrine tumor and rectal cancer: a case report
por: Omori, Sachie, et al.
Publicado: (2020)

Caution for living donor liver transplantation with congenital portosystemic shunt: a case report
por: Nagao, Yoshihiro, et al.
Publicado: (2022)

Donor Skeletal Muscle Quality Affects Graft Mortality After Living Donor Liver Transplantation- A Single Center, Retrospective Study
por: Tomiyama, Takahiro, et al.
Publicado: (2022)

Which is better to use “body weight” or “standard liver weight”, for predicting small‐for‐size graft syndrome after living donor liver transplantation?
por: Toshima, Takeo, et al.
Publicado: (2020)

The authors’ reply: Indispensable discrepancy between predicted graft “volume” and actual graft “weight” in clinical practice in living‐donor liver transplantation
por: Toshima, Takeo, et al.
Publicado: (2021)

Predictor of outcome after living donor liver transplantation for patients with hepatocellular carcinoma beyond the Japan criteria
por: Yonemura, Yusuke, et al.
Publicado: (2020)

Comparison of the prognostic effect of sarcopenia on atezolizumab plus bevacizumab and lenvatinib therapy in hepatocellular carcinoma patients
por: Toshida, Katsuya, et al.
Publicado: (2022)

Prevention of bile duct injury using indocyanine green fluorescence in laparoscopic liver cyst fenestration for giant liver cyst: a case report
por: Shimagaki, Tomonari, et al.
Publicado: (2022)

Identification of CMTM6 and CMTM4 as PD-L1 protein regulators
por: Mezzadra, Riccardo, et al.
Publicado: (2017)

The prognostic impact of programmed cell death ligand 1 and human leukocyte antigen class I in pancreatic cancer
por: Imai, Daisuke, et al.
Publicado: (2017)

Prognostic significance of inflammatory biomarkers in hepatocellular carcinoma following hepatic resection
por: Itoh, S., et al.
Publicado: (2019)

Usefulness of microsurgical back‐table angioplasty for multiple hepatic arteries in living donor liver transplantation
por: Harada, Noboru, et al.
Publicado: (2020)

DsRNA Sequencing for RNA Virus Surveillance Using Human Clinical Samples
por: Izumi, Takuma, et al.
Publicado: (2021)

Living donor liver transplantation indicated for compensated liver cirrhosis with symptomatic gallstone diseases: report of two cases
por: Bekki, Yuki, et al.
Publicado: (2016)

Liver resection with right hepatic vein reconstruction using the internal jugular vein: a case report
por: Shimagaki, Tomonari, et al.
Publicado: (2016)

CMTM6 and CMTM4 as two novel regulators of PD-L1 modulate the tumor microenvironment
por: Zhang, Tong, et al.
Publicado: (2022)

Oncogenic roles of SMARCB1/INI1 and its deficient tumors
por: Kohashi, Kenichi, et al.
Publicado: (2017)

Chronic hepatitis E virus infection after living donor liver transplantation via blood transfusion: a case report
por: Kurihara, Takeshi, et al.
Publicado: (2016)

Efficacy of recombinant thrombomodulin for DIC after deceased donor liver transplantation: a case report
por: Kimura, Koichi, et al.
Publicado: (2016)

Expression Analysis of Canine CMTM6 and CMTM4 as Potential Regulators of the PD-L1 Protein in Canine Cancers
por: Takeuchi, Hiroto, et al.
Publicado: (2020)

CMTM6 and CMTM7: New leads for PD‐L1 regulation in breast cancer cells undergoing EMT
por: Xiao, Malina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tk1628cedbn1njf4614nn6eb3m